146 related articles for article (PubMed ID: 17066467)
1. Etoposide-related secondary acute myeloid leukemia (t-AML) in hemophagocytic lymphohistiocytosis.
Imashuku S
Pediatr Blood Cancer; 2007 Feb; 48(2):121-3. PubMed ID: 17066467
[No Abstract] [Full Text] [Related]
2. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
RamaChandran S; Ariffin H
Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
[TBL] [Abstract][Full Text] [Related]
3. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
Pan H; Feng DN; Song L; Sun LR
BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
[TBL] [Abstract][Full Text] [Related]
5. Etoposide-related cardiotoxicity in a child with haemophagocytic lymphohistiocytosis.
Escoto H; Ringewald J; Kalpatthi R
Cardiol Young; 2010 Feb; 20(1):105-7. PubMed ID: 20181298
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
Weintraub M; Revel-Vilk S; Charit M; Aker M; Pe'er J
J Pediatr Hematol Oncol; 2007 Sep; 29(9):646-8. PubMed ID: 17805043
[TBL] [Abstract][Full Text] [Related]
7. Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Imashuku S; Teramura T; Kuriyama K; Kitazawa J; Ito E; Morimoto A; Hibi S
Int J Hematol; 2002 Feb; 75(2):174-7. PubMed ID: 11939264
[TBL] [Abstract][Full Text] [Related]
8. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
[No Abstract] [Full Text] [Related]
9. [A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis].
Seo YI; Park R; Choi TY; Shin JW; Won JH; Park HS; Lee NS; Cho D
Korean J Lab Med; 2007 Aug; 27(4):244-7. PubMed ID: 18094583
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis.
Sardou-Cezar I; Lopes BA; Andrade FG; Fonseca TCC; Fernandez TS; Larghero P; de Souza RQ; Loth G; Ribeiro LL; Bonfim C; Morgado ES; Marschalek R; Meyer C; Pombo-de-Oliveira MS
Cancer Genet; 2021 Aug; 256-257():86-90. PubMed ID: 34034210
[TBL] [Abstract][Full Text] [Related]
11. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.
O'Brien MM; Lee-Kim Y; George TI; McClain KL; Twist CJ; Jeng M
Pediatr Blood Cancer; 2008 Feb; 50(2):381-3. PubMed ID: 16856156
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of childhood hemophagocytic lymphohistiocytosis: experience of 28 cases].
Xie J; Zhang DW; Yang S; Wu MY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):345-7. PubMed ID: 16923375
[No Abstract] [Full Text] [Related]
13. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
[TBL] [Abstract][Full Text] [Related]
14. An exclusive case of juvenile myelomonocytic leukemia in association with Kikuchi's disease and hemophagocytic lymphohistiocytosis and a review of the literature.
Gerritsen A; Lam K; Marion Schneider E; van den Heuvel-Eibrink MM
Leuk Res; 2006 Oct; 30(10):1299-303. PubMed ID: 16487587
[TBL] [Abstract][Full Text] [Related]
15. Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis: is it secondary leukemia?
Suzuki T; Mugishima H; Yamada A; Nagata T; Shichino H; Chin M; Imashuku S; Harada K
Int J Hematol; 1999 Jul; 70(1):58-9. PubMed ID: 10446498
[No Abstract] [Full Text] [Related]
16. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children.
Lackner H; Urban C; Sovinz P; Benesch M; Moser A; Schwinger W
Haematologica; 2008 Feb; 93(2):291-4. PubMed ID: 18245652
[TBL] [Abstract][Full Text] [Related]
17. Development of secondary T-cell acute lymphoblastic leukemia in a child with hemophagocytic lymphohistiocytosis.
Shamsian BS; Gharib A; Rezaei N; Esfahani SA; Alavi S; Goudarzipour K; Arzanian MT
Pediatr Blood Cancer; 2010 Oct; 55(4):725-6. PubMed ID: 20589661
[TBL] [Abstract][Full Text] [Related]
18. Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis.
Devecioglu O; Anak S; Atay D; Aktan P; Devecioglu E; Ozalp B; Saribeyoglu E
Pediatr Blood Cancer; 2009 Sep; 53(3):491-2. PubMed ID: 19459197
[TBL] [Abstract][Full Text] [Related]
19. Two acute myeloblastic leukemia cases concomitant with hemophagocytic lymphohistiocytosis and review of the literature.
Akyay A; Celkan T; Iskender G; Tükün A; Ogan C; Olcay L
Ann Clin Lab Sci; 2013; 43(1):85-90. PubMed ID: 23462611
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia.
Styczynski J; Toporski J; Wysocki M; Debski R; Chybicka A; Boruczkowski D; Wachowiak J; Wojcik B; Kowalczyk J; Gil L; Balwierz W; Matysiak M; Krawczuk-Rybak M; Balcerska A; Sonta-Jakimczyk D
Anticancer Res; 2007; 27(3B):1547-51. PubMed ID: 17595774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
